Lisdexamfetamine Dimesylate

Overview

Lisdexamfetamine Dimesylate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201178).

Patent & exclusivity (US)

Per the FDA Orange Book (161 approved US products), the latest listed US patent on Lisdexamfetamine Dimesylate expires 29 Aug 2040. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid

Canonical SMILES

C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O

InChIKey

CETWSOHVEGTIBR-FORAGAHYSA-N